CCRIX
Price
$28.48
Change
-$0.26 (-0.90%)
Updated
Sep 12 closing price
Net Assets
2.64B
WCMLX
Price
$13.68
Change
-$0.22 (-1.58%)
Updated
Sep 12 closing price
Net Assets
44.71M
Interact to see
Advertisement

CCRIX vs WCMLX

Header iconCCRIX vs WCMLX Comparison
Open Charts CCRIX vs WCMLXBanner chart's image
Columbia Small Cap Growth R
Price$28.48
Change-$0.26 (-0.90%)
VolumeN/A
Net Assets2.64B
WCM Small Cap Growth Institutional
Price$13.68
Change-$0.22 (-1.58%)
VolumeN/A
Net Assets44.71M
CCRIX vs WCMLX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
CCRIX vs. WCMLX commentary
Sep 13, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CCRIX is a Hold and WCMLX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CCRIX has more cash in the bank: 2.64B vs. WCMLX (44.7M). CCRIX (0.00) and WCMLX (0.00) have matching dividends . CCRIX was incepted earlier than WCMLX: CCRIX (15 years) vs WCMLX (6 years). WCMLX (1.79) is less costly to investors than CCRIX (1.50). CCRIX is a more actively managed with annual turnover of: 146.00 vs. WCMLX (83.00). CCRIX has a lower initial minimum investment than WCMLX: CCRIX (0) vs WCMLX (100000). CCRIX annual gain was more profitable for investors over the last year : 26.83 vs. WCMLX (9.36). WCMLX return over 5 years is better than : 26.36 vs. CCRIX (23.93).
CCRIXWCMLXCCRIX / WCMLX
Total Expense Ratio1.490.99151%
Annual Report Gross Expense Ratio1.501.7984%
Fund Existence15 years6 years-
Gain YTD16.0278.087198%
Front LoadN/AN/A-
Min. Initial Investment0100000-
Min. Initial Investment IRAN/AN/A-
Net Assets2.64B44.7M5,902%
Annual Yield % from dividends0.000.00-
Returns for 1 year26.839.36287%
Returns for 3 years67.8726.71254%
Returns for 5 years23.9326.3691%
Returns for 10 years5.04N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GMUEX14.36N/A
N/A
GMO US Equity III
BGGSX31.46N/A
N/A
Baillie Gifford US Equity Growth I
VPRAX26.63N/A
N/A
VY® T. Rowe Price Capital Apprec R6
AWSSX17.95N/A
N/A
Invesco Global Core Equity R6
MVISX52.31N/A
N/A
Patient Opportunity IS